BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2015
View Archived Issues
IMAB-027 safe and well tolerated in first study in humans
Read More
Lilly presents clinical data on anti-GCGR MAb for diabetes
Read More
First clinical results for nAChR tracer [18F]XTRA
Read More
Corbus Pharmaceuticals' Resunab receives FDA orphan drug designation for systemic sclerosis
Read More
AnGes reports results of pilot study of Ebola vaccine
Read More
DRAM2 mutations linked to retinal dystrophy with early macular degeneration
Read More
Cellmid's CAB-102 shown to be safe in toxicology studies
Read More
Circadian Technologies receives approval from FDA to initiate trial of OPT-302
Read More
Genzyme starts phase I/II trial of olipudase alfa in children with Niemann-Pick disease
Read More
PlasmaTech licenses Fanconi anemia gene therapy and CRISPR gene-editing technology
Read More
Avalanche Biotechnologies reports phase IIa findings for AVA-101 in wet AMD
Read More
U.S. researchers patent new antivirals
Read More
Laurent Pharmaceuticals' Lau-7b is safe and well tolerated in patients with cystic fibrosis
Read More
Pharmascience describes BTK inhibitors
Read More
Universiteit Ghent discloses peloruside analogues
Read More
Spanish scientists report vitamin D analogues
Read More
Sunshine Lake Pharma develops anti-HBV agents
Read More
RedHill Biopharma's RHB-105 meets primary endpoint in phase III H. pylori infection trial
Read More
Neovacs launches clinical development program in dermatomyositis
Read More
BioBlast initiates phase III study of Cabaletta in oculopharyngeal muscular dystrophy
Read More
Atara Biotherapeutics exercises option to T-cell technology from MSK
Read More
FDA accepts Teva's BLA for reslizumab in asthma with elevated eosinophil levels
Read More
Chiasma files NDA for oral octreotide in acromegaly
Read More
Pre-EUA dossier for Cleveland Biolabs' entolimod submitted to FDA
Read More